NCT00160654 - Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy | Biotech Hunter

Enrollment

251

Participants

Timeline

Start Date

November 24, 2003

Primary Completion Date

December 12, 2006

Study Completion Date

December 12, 2006

Conditions

Epilepsy, Partial

Interventions

DRUG

Levetiracetam

"* Pharmaceutical form: oral tablets~* Concentration: 500 mg~* Route of administration: Oral use"

Trial Locations (29)

N01036 808, Hong Kong

N01036 842, Hong Kong

N01036 815, Kwun Tong

N01036 811, Kuala Lumpur

N01036 812, Kuala Lumpur

N01036 813, Kuala Lumpur

N01036 830, Manila

N01036 831, Manila

N01036 829, Quezon

N01036 804, Singapore

N01036 806, Singapore

N01036 807, Singapore

N01036 828, Changhua

N01036 827, Hualien City

N01036 825, Kaohsiung City

N01036 834, Kaohsiung City

N01036 835, Kaohsiung City

N01036 817, Taichung

N01036 823, Taichung

N01036 818, Tainan City

N01036 819, Taipei

N01036 820, Taipei

N01036 821, Taipei

N01036 822, Taoyuan District

N01036 809, Bangkok

N01036 840, Bangkok

N01036 841, Bangkok

N01036 839, Chiang Mai

N01036 810, Khon Kaen